NEW YORK, May 29, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Apollo Education Group, Inc. (NASDAQ: APOL), DeVry Education Group Inc. (NYSE: DV), ITT Educational Services, Inc. (NYSE: ESI), KBR, Inc. (NYSE: KBR) and URS Corporation (NYSE: URS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3071-100free.

-- Apollo Education Group, Inc. Analyst Notes On May 20, 2014, Apollo Education Group, Inc. (Apollo) announced that its wholly-owned subsidiary Apollo Global, Inc. has closed on the acquisition of an 81% consolidated interest in Milpark Education (Pty) Ltd. (Milpark Education) for approximately (South African rand) ZAR 265 million. According to the Company, Milpark Education is well-known and specialized in South Africa with a range of offerings tailored to working adult learners, including qualifications in business, commerce, investment, banking, financial planning, insurance, and government and public management. Apollo's CEO, Greg Cappelli, said, "Aligned with our diversification strategy, Milpark Education brings tremendous value, academic content and expertise serving adult learners. Expanding into South Africa allows us to broaden our network of global educational institutions. We look forward to exploring other opportunities to serve students on the continent of Africa, which hosts seven of the fastest growing economies in the world." The Company does not expect the transaction to have a material impact on its FY 2014 financial results. The full analyst notes on Apollo Global, Inc. are available to download free of charge at:

http://www.analystsreview.com/APOL.pdf/Register

-- DeVry Education Group Inc. Analyst Notes On May 23, 2014, Chamberlain College of Nursing LLC (Chamberlain), a part of DeVry Education Group Inc. (DeVry) has named Carla Sanderson, PhD, MSN, RN, as Vice President of accreditation and professional regulation, effective June 2, 2014. According to the Company, in the new role, Dr. Sanderson will oversee Chamberlain's state board and accreditation agency approvals and will direct institutional and programmatic accreditation processes, approvals, and recognitions. Susan Groenwald, PhD, MSN, RN, President of Chamberlain said, "Dr. Sanderson's breadth of experience managing accreditation for academic institutions will be invaluable as she continues to uphold Chamberlain's commitment to the highest standards of academic quality." The full analyst notes on DeVry are available to download free of charge at:

http://www.analystsreview.com/DV.pdf/Register

-- ITT Educational Services, Inc. Analyst Notes On May 22, 2014, ITT Educational Services, Inc. reported its preliminary Q1 2014 enrolment results. New student enrolment in Q1 2014 decreased 3.8% YoY to 16,746 in March 31, 2014, and total student enrolment decreased 6.4% YoY to 57,125, compared with 61,039 in March 31, 2013. The full analyst notes on ITT Educational Services are available to download free of charge at:

http://www.analystsreview.com/ESI.pdf/Register

-- KBR, Inc. Analyst Notes On May 22, 2014, KBR, Inc. (KBR) announced that a project management consultancy (PMC) services contract has been awarded to the Company for the construction of an advanced oil processing complex in Russia owned by JSC Gazprom Neft. KBR informed that it will provide PMC services for three new process units and off sites and utilities construction beginning with the front-end engineering and design phase and continuing through EPC, commissioning and start-up. The full analyst notes on KBR are available to download free of charge at:

http://www.analystsreview.com/KBR.pdf/Register

-- URS Corporation Analyst Notes On May 13, 2014, URS Corporation (URS) reported its Q1 FY 2014 financial results (period ended April 4, 2014). Quarterly revenues fell 9.5% YoY to $2.5 billion during the quarter. Operating income was $87 million, compared with $153 million in Q1 FY 2013. Q1 FY 2014 net income attributable to URS was $27 million, or $0.37 per diluted share, compared with $72 million, or $0.96 per diluted share in Q1 FY 2013. During the quarter, revenues and operating income derived from chemical demilitarization program decreased $163 million and $67 million, respectively on YoY basis. Meanwhile, net income generated by the chemical demilitarization contracts for the quarter decreased c.$40 million, or $0.54 per share (diluted) on YoY basis. The full analyst notes on URS are available to download free of charge at:

http://www.analystsreview.com/URS.pdf/Register

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review